TEE
BIIB icon

Tibra Equities Europe’s Biogen BIIB Stock Holding History

Tibra Equities Europe’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-22,000
Closed -$5.12M – 192
2019
Q3 		$5.12M Buy
+22,000
New +$5.12M 0.63% 35
2018
Q4 		– Sell
-32,542
Closed -$11.5M – 195
2018
Q3 		$11.5M Buy
+32,542
New +$11.2M 1.36% 16

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Tibra Equities Europe's BIIB Position: Q4 2019 in Review

Tibra Equities Europe sold out of Biogen (BIIB) in Q4 2019, closing a stake of 22,000 shares — an estimated $5.12M sold.

Tibra Equities Europe first reported a position in BIIB in Q3 2018 and held it in 2 quarters. The position peaked at $11.5M in Q3 2018. 1,103 funds tracked by Wall St. Rank hold BIIB as of Q4 2019.

  • Tibra Equities Europe reported no remaining Biogen position as of Q4 2019 after selling out during the quarter.
  • Tibra Equities Europe sold 22,000 Biogen shares in Q4 2019, an estimated $5.12M.
  • Tibra Equities Europe first reported a position in Biogen in Q3 2018 and held it in 2 quarters.
  • Tibra Equities Europe's Biogen position peaked at $11.5M in Q3 2018.
  • 1,103 funds tracked by Wall St. Rank held Biogen as of Q4 2019.

Based on Tibra Equities Europe's 13F filing for Q4 2019, filed 14 Feb 2020.